Caphealthy Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 07-11-2024
- Paid Up Capital ₹ 4.00 M
as on 07-11-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 55.75%
(FY 2023)
- Profit 75.05%
(FY 2023)
- Ebitda 129.77%
(FY 2023)
- Net Worth 169.69%
(FY 2023)
- Total Assets 111.95%
(FY 2023)
About Caphealthy Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rashmi Desai, Vandana Chari, and Gayle Araujo serve as directors at the Company.
- CIN/LLPIN
U24230GA2020PTC014503
- Company No.
014503
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
North Goa, Goa, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Caphealthy Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rashmi Desai  | Director | 21-Sep-2020 | Current |
| Vandana Chari | Director | 21-Sep-2020 | Current |
| Gayle Araujo | Director | 17-Nov-2020 | Current |
Financial Performance and Corporate Structure Insights of Caphealthy Pharma.
Caphealthy Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 55.75% increase. The company also saw a substantial improvement in profitability, with a 75.05% increase in profit. The company's net worth Soared by an impressive increase of 169.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Caphealthy Pharma?
Unlock access to Caphealthy Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Action Agro (India) Private LimitedActive 15 years 11 monthsRashmi Desai and Vandana Chari are mutual person
- Vedas Realtors Private LimitedActive 18 years 6 months
Rashmi Desai and Vandana Chari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Caphealthy Pharma?
Caphealthy Pharma has a workforce of 51 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Caphealthy Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Caphealthy Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
